Bioprospecting for extracellular enzymes from culturable Actinobacteria from the South Shetland Islands, Antarctica.

Gespeichert in:
Bibliographische Detailangaben
Titel: Bioprospecting for extracellular enzymes from culturable Actinobacteria from the South Shetland Islands, Antarctica.
Autoren: Lamilla, Claudio, Pavez, Mónica, Santos, Andrés, Hermosilla, Andrea, Llanquinao, Vicente, Barrientos, Leticia
Quelle: Polar Biology; Mar2017, Vol. 40 Issue 3, p719-726, 8p, 2 Charts, 1 Graph
Schlagwörter: EXTRACELLULAR enzymes, ACTINOBACTERIA, BREVIBACTERIUM, BIOTECHNOLOGY, GELATINASES
Geografische Kategorien: SOUTH Shetland Islands (Antarctica)
Abstract: The development of novel biological products, such as enzymes, dyes, antibiotics, and others with high potential use for biotechnological applications, continues to stimulate the search for microorganisms in extreme environments. In recent years, the study of Antarctic ecosystems and their microorganisms has received more attention because psychrophilic microorganisms-mainly bacteria and their enzymes-have assumed considerable importance for biotechnological applications. In this study, we characterized a collection of 30 culturable Actinobacteria isolated from the South Shetland Islands, Antarctica, in order to relate their distribution and ability to produce extracellular enzymes with their biotechnological potential. The isolates belonged to eight genus in the phylum Actinobacteria: Arthrobacter, Brevibacterium, Curtobacterium, Janibacter, Knoellia, Rhodococcus, Streptomyces and Thermoleophilum. The screening for biologically active products showed that all the evaluated strains produced at least one extracellular enzyme at 4 °C, with protease, gelatinase and cellulase enzymes being the most common. In conclusion, our data showed that various Antarctic ecosystems are good sources for isolating cultivable Actinobacteria. Furthermore, these bacteria provide high-quality biological material for screening cold-active enzymes that have potential biotechnological applications and economic benefits. [ABSTRACT FROM AUTHOR]
Copyright of Polar Biology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Datenbank: Complementary Index
Beschreibung
Abstract:The development of novel biological products, such as enzymes, dyes, antibiotics, and others with high potential use for biotechnological applications, continues to stimulate the search for microorganisms in extreme environments. In recent years, the study of Antarctic ecosystems and their microorganisms has received more attention because psychrophilic microorganisms-mainly bacteria and their enzymes-have assumed considerable importance for biotechnological applications. In this study, we characterized a collection of 30 culturable Actinobacteria isolated from the South Shetland Islands, Antarctica, in order to relate their distribution and ability to produce extracellular enzymes with their biotechnological potential. The isolates belonged to eight genus in the phylum Actinobacteria: Arthrobacter, Brevibacterium, Curtobacterium, Janibacter, Knoellia, Rhodococcus, Streptomyces and Thermoleophilum. The screening for biologically active products showed that all the evaluated strains produced at least one extracellular enzyme at 4 °C, with protease, gelatinase and cellulase enzymes being the most common. In conclusion, our data showed that various Antarctic ecosystems are good sources for isolating cultivable Actinobacteria. Furthermore, these bacteria provide high-quality biological material for screening cold-active enzymes that have potential biotechnological applications and economic benefits. [ABSTRACT FROM AUTHOR]
ISSN:07224060
DOI:10.1007/s00300-016-1977-z